- Home
- Publications
- Publication Search
- Publication Details
Title
Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
Authors
Keywords
-
Journal
EMBO JOURNAL
Volume -, Issue -, Pages -
Publisher
EMBO
Online
2020-12-04
DOI
10.15252/embj.2020106501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019
- (2020) Yonghong Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2
- (2020) Xuesen Zhao et al. JOURNAL OF VIROLOGY
- Syncytia formation by SARS‐CoV‐2 infected cells
- (2020) Julian Buchrieser et al. EMBO JOURNAL
- IFITM3 directly engages and shuttles incoming virus particles to lysosomes
- (2018) Jennifer S. Spence et al. Nature Chemical Biology
- mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3
- (2018) Guoli Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
- (2018) Mahesh Chemudupati et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity
- (2017) Temet M. McMichael et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses
- (2017) Xuesen Zhao et al. JOURNAL OF VIROLOGY
- SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans
- (2017) E Kaitlynn Allen et al. NATURE MEDICINE
- Δ20 IFITM2 differentially restricts X4 and R5 HIV-1
- (2017) Wan-Lin Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural mutations in IFITM3 modulate post‐translational regulation and toggle antiviral specificity
- (2016) Alex A Compton et al. EMBO REPORTS
- Mass-tag labeling reveals site-specific and endogenous levels of protein S-fatty acylation
- (2016) Avital Percher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells
- (2015) William Melvin et al. Viruses-Basel
- Identification of an endocytic signal essential for the antiviral action of IFITM3
- (2014) Rui Jia et al. CELLULAR MICROBIOLOGY
- Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications
- (2014) Nicholas M Chesarino et al. Future Microbiology
- Phosphorylation of the Antiviral Protein Interferon-inducible Transmembrane Protein 3 (IFITM3) Dually Regulates Its Endocytosis and Ubiquitination
- (2014) Nicholas M. Chesarino et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
- (2014) X. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms
- (2014) Florian Wrensch et al. Viruses-Basel
- IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
- (2014) Charles C. Bailey et al. Annual Review of Virology
- TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium
- (2013) S. Bertram et al. JOURNAL OF VIROLOGY
- Palmitoylation on Conserved and Nonconserved Cysteines of Murine IFITM1 Regulates Its Stability and Anti-Influenza A Virus Activity
- (2013) J. C. Hach et al. JOURNAL OF VIROLOGY
- The CD225 Domain of IFITM3 Is Required for both IFITM Protein Association and Inhibition of Influenza A Virus and Dengue Virus Replication
- (2013) S. P. John et al. JOURNAL OF VIROLOGY
- Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-Mediated Restriction
- (2013) Tsai-Yu Lin et al. Cell Reports
- IFITM Proteins Restrict Viral Membrane Hemifusion
- (2013) Kun Li et al. PLoS Pathogens
- S-Palmitoylation and Ubiquitination Differentially Regulate Interferon-induced Transmembrane Protein 3 (IFITM3)-mediated Resistance to Influenza Virus
- (2012) Jacob S. Yount et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular Localization
- (2012) R. Jia et al. JOURNAL OF VIROLOGY
- IFITM3 restricts the morbidity and mortality associated with influenza
- (2012) Aaron R. Everitt et al. NATURE
- A diverse range of gene products are effectors of the type I interferon antiviral response
- (2011) John W. Schoggins et al. NATURE
- IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
- (2011) Eric M. Feeley et al. PLoS Pathogens
- Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
- (2011) I-Chueh Huang et al. PLoS Pathogens
- Palmitoylome profiling reveals S-palmitoylation–dependent antiviral activity of IFITM3
- (2010) Jacob S Yount et al. Nature Chemical Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started